These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 2937888

  • 1. Temporal changes of suppressor T lymphocytes and cytotoxic T lymphocytes in syngeneic murine malignant gliomas.
    Yamasaki T, Handa H, Yamashita J, Namba Y, Hanaoka M.
    J Neurooncol; 1986; 3(4):353-62. PubMed ID: 2937888
    [Abstract] [Full Text] [Related]

  • 2. [Effects of adult thymectomy on the growth of 203-glioma in mice--analysis of T cell subpopulation in tumor immunology].
    Yamasaki T, Yamashita J, Handa H, Namba Y, Hanaoka M.
    No To Shinkei; 1982 Nov; 34(11):1067-75. PubMed ID: 6984337
    [Abstract] [Full Text] [Related]

  • 3. [Suppressor mechanism in tumor immunology: characteristics of suppressor T-cells in glioma-bearing mice].
    Yamasaki T, Yamashita J, Handa H, Namba Y, Hanaoka M.
    No To Shinkei; 1983 Jul; 35(7):703-9. PubMed ID: 6194806
    [Abstract] [Full Text] [Related]

  • 4. Immunoregulatory effects of interleukin 2 and interferon on syngeneic murine malignant glioma-specific cytotoxic T-lymphocytes.
    Yamasaki T, Kikuchi H, Yamashita J, Handa H, Kuwata S, Taguchi M, Namba Y, Hanaoka M.
    Cancer Res; 1988 Jun 01; 48(11):2981-7. PubMed ID: 3259157
    [Abstract] [Full Text] [Related]

  • 5. Lyt-2+ suppressor T cells are resistant to anti-Lyt-2 antibody blocking.
    Hollander N.
    J Immunol; 1985 Apr 01; 134(4):2205-8. PubMed ID: 2579133
    [Abstract] [Full Text] [Related]

  • 6. Characteristic immunological responses to an experimental mouse brain tumor.
    Yamasaki T, Handa H, Yamashita J, Namba Y, Hanaoka M.
    Cancer Res; 1983 Oct 01; 43(10):4610-7. PubMed ID: 6603902
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Role of cytotoxic T lymphocytes in the prevention of lupus-like disease occurring in a murine model of graft-vs-host disease.
    Via CS, Sharrow SO, Shearer GM.
    J Immunol; 1987 Sep 15; 139(6):1840-9. PubMed ID: 2957440
    [Abstract] [Full Text] [Related]

  • 11. Down-regulation of cytotoxic T lymphocyte development by a minor stimulating locus-induced suppressor cascade that involves Lyt-1+ suppressor T cells, IA- macrophages, and their factors.
    Chow KP, Battisto JR.
    J Immunol; 1988 Feb 15; 140(4):1005-13. PubMed ID: 2963857
    [Abstract] [Full Text] [Related]

  • 12. An experimental approach to specific adoptive immunotherapy for malignant brain tumors.
    Yamasaki T, Kikuchi H.
    Nihon Geka Hokan; 1989 Nov 01; 58(6):485-92. PubMed ID: 2519184
    [Abstract] [Full Text] [Related]

  • 13. Generation of antisuppressor T cells for alloreactive cytotoxic T lymphocytes.
    Ting CC, Hargrove ME.
    J Immunol; 1987 Dec 15; 139(12):3964-72. PubMed ID: 2961802
    [Abstract] [Full Text] [Related]

  • 14. A syngeneic splenic cell antigen induces a suppressor T cell in lymph nodes that controls cytotoxic T-cell and primary antibody responses.
    Emara M, Battisto JR.
    Cell Immunol; 1987 Mar 15; 105(1):205-19. PubMed ID: 2949860
    [Abstract] [Full Text] [Related]

  • 15. Cytotoxic T lymphocytes reactive against a syngeneic murine tumor and their specific suppressor T cells are both elicited by in vitro allosensitization.
    Leshem B, Kedar E.
    J Exp Med; 1990 Apr 01; 171(4):1057-71. PubMed ID: 2139097
    [Abstract] [Full Text] [Related]

  • 16. Generation of specific antitumor cytotoxic T-lymphocytes in monoculture can be inhibited by T-suppressors from tumor-bearing mice.
    Lupatov AYu, Brondz BD.
    Cancer Biother; 1994 Apr 01; 9(2):123-9. PubMed ID: 7812361
    [Abstract] [Full Text] [Related]

  • 17. Specific adoptive immunotherapy of malignant glioma with long-term cytotoxic T lymphocyte line expanded in T-cell growth factor. Experimental study and future prospects.
    Yamasaki T, Handa H, Yamashita J, Watanabe Y, Namba Y, Hanaoka M.
    Neurosurg Rev; 1984 Apr 01; 7(1):37-54. PubMed ID: 6611523
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Cell-mediated immune responses to syngeneic tumors. I. Identification of two distinct CTL effector pathways which differ in antigen specificity, genetic regulation, and cell surface phenotype.
    Lynch DH, Daynes RA, Hodes RJ.
    J Immunol; 1986 Feb 15; 136(4):1521-7. PubMed ID: 2418117
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.